Using the VLP-based approach to target STING in human T-cell lymphoma cells (CUTLL-1) and human T-ALL cells (DND41), we observed significantly reduced viability of both human cell lines via induction of apoptosis (Fig. 6f). This evidence concerns the gene STING1 and acute lymphoblastic leukemia.